Somatostatin receptor scintigraphy. When should a SPECT study be performed?;Gammagrafía de receptores de somatostatina. ¿Cuándo hacer una SPECT?

Revista Espanola de Medicina Nuclear

Volumn 22, Issue 2, 2003, Pages 68-75

  Banzo, J ^a   Abos M D ^a   Garcia S ^b   Prats, E ^a   Razola, P ^a   Alonso, V ^b   Garcia F ^a   Ubieto, M A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Carcinoid tumor; Pancreatic neuroendocrine tumors; Somatostatin receptor scintigraphy; SPECT

Indexed keywords

SOMATOSTATIN RECEPTOR;

ARTICLE; CANCER SCINTISCANNING; CARCINOID; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GAMMA RADIATION; HUMAN; MALE; PANCREAS CANCER; SENSITIVITY ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ADULT; AGED; METASTASIS; MIDDLE AGED; NEUROENDOCRINE TUMOR; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOID TUMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; RECEPTORS, SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0642317140     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1157/13044673     Document Type: Article

References (25)

1. Blok D, Feitsma RIJ, Vermeij P, Pauwels EJK. Peptide radiopharmaceuticals in nuclear medicine. Eur J Nucl Med 1999;26:1511-20.
2. Kvols LK. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging, and treatment of tumors. Gastroenterology 1993;105:1090-1.
3. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann Inter Med 1996; 125:26-34.
4. Krausz Y, Bar-Ziv J, De Jong RBJ, Ish-Shalom S, Chisin R, Shibley N, et al. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors. Am J Gastroenterol 1998;93:66-70.
5. Chiti A, Fanti S, Savelli G, Romeo A, Bellanova B, Rodari M, et al. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med 1998;25:1396-03.
6. 111In-pentetreótida en el estudio de tumores que expresan receptores para la somatostatina. Rev Esp Med Nucl 1999; 18:325-30.
7. Zimmer T, Scherubl H, Faiss S, Stolzel U, Riecken EO, Wiedenmann B. Endoscopic ultrasonography of neurendocrine tumours. Digestion 2000;62(Suppl 1):45-50.
8. 111indium-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patients management. J Nucl Med 1995;36:542-9.
9. Lebtahi R, Cadiot G, Sardá L, Daou D, Faraggi M, Petegnief Y, et al. Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997;38:853-8.
10. Frilling A, Malago M, Martin H, Broelsch CE. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors. Surgery 1998;124:1000-4.
11. Kvols LK, Reubi JC. The presence of somatostatin receptors in malignant neuroendocrine tumor tissue predicts responsiveness to octreotide. Yale J Biol Med 1992;65:505-12.
12. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin analogues. Digestion 2000; 62(Suppl 1):84-91.
13. Kwekkeboom D, Krenning EP, De Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000;41:1704-13.
14. Slooter GD, Mearadji A, Breeman WAP, Marquet RL, De Jong M, Krenning EP, et al. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. Br J Surg 2001;88:31-40.
15. Modlin IM, Tang LH. Approaches to the diagnosis of gut neuroendocrine tumors: the last word (today). Gastroenterology 1997;112:583-90.
16. Ricke J, Klose KJ. Imaging procedures in neuroendocrine tumours. Digestion 2000;62(Suppl. 1):39-44.
17. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. En: Freeman LM, ed. Nuclear Medicine Annual 1995. Filadelfia: Lippincott-Raven; 1995. p. 1-50.
18. Kisker O, Weinel RJ, Geks J, Zacara F, Joseph K, Rothmund M. Value of somatostatin receptor scintigraphy for preoperative locazation of carcinoids. World J Surg 1996;20:162-7.
19. Musi M, Carbone RG, Bertocchi C, Cantalupi DP, Michetti G, Pugliese C, et al. Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy. Lung Cancer 1998;22:97-02.
20. Cadiot G, Lebtahi R, Sardá L, Bonnaud G, Marmuse JP, Vissuzaine C, et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996;111:845-54.
21. Zimmer T, Ziegler K, Bäder M, Fett U, Hamm B, Riecken EO, et al. Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut 1994;35:471-5.
22. Schillaci O, Scopinaro F, Angeletti S, Tavoloro R, Danieli R, Annibale B, et al. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996;37:1452-6.
23. 111In-Pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 2000;41:559-62.
24. Gibril F, Reynolds JC, Lubensky IA, Peghini PL, Doppman JL, et al. Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. J Nucl Med 2000;41:1646-56.
25. Banzo J, Abós MD, Prats E, García F, Freile E, Razola P, et al. Tumor carcinoide bronquial y gammagrafía de receptores de somatostatina: detección de metástasis óseas. Rev Esp Med Nucl 2001;20:431-8.